<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.827826</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107144910</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">161118s2016    onc    |o    f|0| 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">XC62-1/1-421-4E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="110" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Parliament. </marc:subfield>
      <marc:subfield code="b">House of Commons. </marc:subfield>
      <marc:subfield code="b">Standing Committee on Health.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Interim report and recommendations on the opioid crisis in Canada </marc:subfield>
      <marc:subfield code="h">[electronic resource] / </marc:subfield>
      <marc:subfield code="c">Bill Casey, Chair.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">House of Commons, </marc:subfield>
      <marc:subfield code="c">2016.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">vii, 36 p.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="490" ind1="1" ind2=" ">
      <marc:subfield code="a">Report of the Standing Committee on Health ; </marc:subfield>
      <marc:subfield code="v">4th report, 1st session, 42nd Parliament</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Also available in French under title: Rapport provisoire et recommandations sur la crise des opioïdes au Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Original published on: 2016/11/18; published on: 2017/02/03; published on: 2018/01/18.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"November 2016."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographical references.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"The emergence of fentanyl and its analogues, an opioid at least 100 times more potent than morphine, has given rise to a public health crisis in Canada requiring urgent action. British Columbia alone is expected to experience 800 illicit drug overdose deaths by the end of 2016, half of which are expected to involve fentanyl. According to the Canadian Centre on Substance Abuse (CCSA), there were at least 655 fentanylimplicated deaths in Canada between 2009 and 2014, representing an average of one fentanyl-implicated death every three days. The unknown potency of fentanyl and other synthetic opioids means that all individuals that engage in illicit drug use are at risk of experiencing overdose and death, from recreational users to habitual users to those trying these drugs for the first time. As these trends show no sign of abating, this crisis will continue to affect individuals and families in communities all across the country"--Introduction.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Health hazards</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Narcotics</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Drug use</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="720" ind1="1" ind2=" ">
      <marc:subfield code="a">Casey, Bill</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Rapport provisoire et recommandations sur la crise des opioïdes au Canada </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.827831</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="830" ind1="#" ind2="0">
      <marc:subfield code="a">Report of the Standing Committee on Health ;</marc:subfield>
      <marc:subfield code="v">4th report, 1st session, 42nd Parliament</marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.507061</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">905 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2016/parl/xc62-1/XC62-1-1-421-4-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
